8 research outputs found
Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study
<div><p>Background</p><p>The link of low estimated glomerular filtration rate (eGFR) and high proteinuria to cardiovascular disease (CVD) mortality is well known. However, its link to mortality due to other causes is less clear.</p><p>Methods</p><p>We studied 367,932 adults (20β93 years old) in the Korean Heart Study (baseline between 1996β2004 and follow-up until 2011) and assessed the associations of creatinine-based eGFR and dipstick proteinuria with mortality due to CVD (1,608 cases), cancer (4,035 cases), and other (non-CVD/non-cancer) causes (3,152 cases) after adjusting for potential confounders.</p><p>Results</p><p>Although cancer was overall the most common cause of mortality, in participants with chronic kidney disease (CKD), non-CVD/non-cancer mortality accounted for approximately half of cause of death (47.0%for eGFR <60 ml/min/1.73m<sup>2</sup> and 54.3% for proteinuria β₯1+). Lower eGFR (<60 vs. β₯60 ml/min/1.73m<sup>2</sup>) was significantly associated with mortality due to CVD (adjusted hazard ratio 1.49 [95% CI, 1.24β1.78]) and non-CVD/non-cancer causes (1.78 [1.54β2.05]). The risk of cancer mortality only reached significance at eGFR <45 ml/min/1.73m<sup>2</sup> when eGFR 45β59 ml/min/1.73m<sup>2</sup> was set as a reference (1.62 [1.10β2.39]). High proteinuria (dipstick β₯1+ vs. negative/trace) was consistently associated with mortality due to CVD (1.93 [1.66β2.25]), cancer (1.49 [1.32β1.68]), and other causes (2.19 [1.96β2.45]). Examining finer mortality causes, low eGFR and high proteinuria were commonly associated with mortality due to coronary heart disease, any infectious disease, diabetes, and renal failure. In addition, proteinuria was also related to death from stroke, cancers of stomach, liver, pancreas, and lung, myeloma, pneumonia, and viral hepatitis.</p><p>Conclusion</p><p>Low eGFR was associated with CVD and non-CVD/non-cancer mortality, whereas higher proteinuria was consistently related to mortality due to CVD, cancer, and other causes. These findings suggest the need for multidisciplinary prevention and management strategies in individuals with CKD, particularly when proteinuria is present.</p></div
Hazard ratios (95%CI) for cause-specific mortality by dipstick proteinuria in Korean Heart Study.
<p>Hazard ratios (95%CI) for cause-specific mortality by dipstick proteinuria in Korean Heart Study.</p
Adjusted hazard ratios of cause-specific mortality for eGFR<60 ml/min/1.73m<sup>2</sup> (vs.β₯60).
<p>Adjusted hazard ratios of cause-specific mortality for eGFR<60 ml/min/1.73m<sup>2</sup> (vs.β₯60).</p
Hazard ratios (95%CI) for cause-specific mortality by eGFR in Korean Heart Study.
<p>Hazard ratios (95%CI) for cause-specific mortality by eGFR in Korean Heart Study.</p
Age-standardized mortality rate (per 1000 person-years) by eGFR.
<p>Age-standardized mortality rate (per 1000 person-years) by eGFR.</p
Adjusted hazard ratios of cause-specific mortality for positive dipstick proteinuria (β₯+ vs. none/trace).
<p>Adjusted hazard ratios of cause-specific mortality for positive dipstick proteinuria (β₯+ vs. none/trace).</p
Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium
OBJECTIVE:To evaluate the associations between adiposity measures (body mass index, waist circumference, and waist-to-height ratio) with decline in glomerular filtration rate (GFR) and with all cause mortality. DESIGN:Individual participant data meta-analysis. SETTING:Cohorts from 40 countries with data collected between 1970 and 2017. PARTICIPANTS:Adults in 39 general population cohorts (n=5β459β014), of which 21 (n=594β496) had data on waist circumference; six cohorts with high cardiovascular risk (n=84β417); and 18 cohorts with chronic kidney disease (n=91β607). MAIN OUTCOME MEASURES:GFR decline (estimated GFR decline β₯40%, initiation of kidney replacement therapy or estimated GFR <10 mL/min/1.73 m2) and all cause mortality. RESULTS:Over a mean follow-up of eight years, 246β607 (5.6%) individuals in the general population cohorts had GFR decline (18β118 (0.4%) end stage kidney disease events) and 782β329 (14.7%) died. Adjusting for age, sex, race, and current smoking, the hazard ratios for GFR decline comparing body mass indices 30, 35, and 40 with body mass index 25 were 1.18 (95% confidence interval 1.09 to 1.27), 1.69 (1.51 to 1.89), and 2.02 (1.80 to 2.27), respectively. Results were similar in all subgroups of estimated GFR. Associations weakened after adjustment for additional comorbidities, with respective hazard ratios of 1.03 (0.95 to 1.11), 1.28 (1.14 to 1.44), and 1.46 (1.28 to 1.67). The association between body mass index and death was J shaped, with the lowest risk at body mass index of 25. In the cohorts with high cardiovascular risk and chronic kidney disease (mean follow-up of six and four years, respectively), risk associations between higher body mass index and GFR decline were weaker than in the general population, and the association between body mass index and death was also J shaped, with the lowest risk between body mass index 25 and 30. In all cohort types, associations between higher waist circumference and higher waist-to-height ratio with GFR decline were similar to that of body mass index; however, increased risk of death was not associated with lower waist circumference or waist-to-height ratio, as was seen with body mass index. CONCLUSIONS:Elevated body mass index, waist circumference, and waist-to-height ratio are independent risk factors for GFR decline and death in individuals who have normal or reduced levels of estimated GFR